Here are 2 ASX finds I'd buy to double my money in 5 years

I think these investment picks can significantly outperform over the next few years.

| More on:
A woman sits at her computer with her hand to her mouth and a contemplative smile on her face as she reads about the performance of Allkem shares on her computer

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Key points

  • Businesses that are growing profit have a great chance of achieving good returns
  • The Vaneck Morningstar Wide Moat ETF has delivered excellent returns with undervalued businesses that have strong competitive advantages
  • Allied health business Healthia is growing its clinic network and seeing operating leverage

Some ASX shares are known for delivering dividends to investors while others are better known for their capital growth potential. I'm going to talk about two investments that I think could deliver excellent returns for investors.

I'm a big fan of ASX tech shares, but they're not the only place to look for opportunities that could achieve considerable growth over the long term.

Vaneck Morningstar Wide Moat ETF (ASX: MOAT)

This ASX-listed exchange-traded fund (ETF) is all about investing in competitively advantaged businesses. Advantages can come in many forms such as brand power, patents, intellectual property, or lower costs than competitors.

Morningstar analysts expect these competitive advantages to last for at least a decade and, more likely than not, for two decades.

With this shortlist of competitively advantaged companies, the analysts only decide to invest if they think the companies are valued at good prices compared to what the analysts determine is a good price.

I think this investment style is well-suited to produce strong long-term returns as it tends to invest in strong, long-term businesses at good prices.

Of course, past performance is not a guarantee of future returns but over the past five years, the MOAT ETF has delivered average returns per annum of 16.7%. If it achieved the same return over the next five years, it would grow a starting investment of $1,000 to more than $2,100 by the end of that period.

Healthia Ltd (ASX: HLA)

Healthia is a promising ASX growth share in my opinion. The business is an allied health company with a network of optometry, podiatry, and physiotherapy clinics around Australia. The company also has its iOrthotics division, which it touts as Australia's "leading manufacturer of custom-made and 3D printed foot orthotic devices for podiatrists".

I think a combination of long-term organic growth of clinic revenue, as well as ongoing acquisitions, will help the business deliver impressive returns over the long term as scale leads to improving profit margins.

The FY23 half-year result was a great example of this. Underlying revenue rose 34.3% year over year, with organic revenue of 5.4%. At the same time, underlying earnings before interest, tax, depreciation and amortisation (EBITDA) grew by 48.2% to $18.1 million (faster than revenue growth).

It also noted that during the period, it invested $8.3 million to acquire 10 physiotherapy clinics and two hand therapy clinics. At the same time, it invested $1.9 million into expanding service offerings within eight existing clinics.

The company has noted it had a market share of less than 3% of the addressable industry revenue. It also said it was reviewing more than 100 allied health businesses as part of an "active acquisition pipeline". Those future acquisitions are expected to be funded from cash and existing bank facilities.

If the ASX share can grow its market share to 6% then I think its profit and the Healthia share price can double as well.

Motley Fool contributor Tristan Harrison has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Healthia. The Motley Fool Australia has recommended Healthia and VanEck Morningstar Wide Moat ETF. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Opinions

Modern accountant woman in a light business suit in modern green office with documents and laptop.
Opinions

Too high? These 2 ASX shares might be due for a correction

These popular blue chips are looking dicey to me.

Read more »

A woman looks questioning as she puts a coin into a piggy bank.
Opinions

The ASX 200 is approaching its all-time high. Here's why I'm not buying shares

I'm not seeing what the broader market is.

Read more »

Warren Buffett
Opinions

Three ASX 200 shares Warren Buffett could buy

If Warren Buffett had to add three ASX shares to his portfolio, he would likely look at these three top…

Read more »

A young woman sits with her hand to her chin staring off to the side thinking about her investments.
Opinions

Could Soul Patts shares hit $50 in 2025?

This company jumped more than 16% yesterday.

Read more »

A male investor sits at his desk looking at his laptop screen holding his hand to his chin pondering whether to buy Macquarie shares
Opinions

3 great lessons I learned being an owner of Brickworks shares

I’m going to take these lessons with me.

Read more »

A bricklayer peers over the top of a brick wall he is laying with a level measuring tool on top and looks critically at the work he is carrying out.
Opinions

The pros and cons of the Soul Patts and Brickworks merger

This is a big deal. What are the positives and negatives of the merger?

Read more »

Piggy bank at the end of a winding road.
Opinions

My top 3 picks in the ASX 20 in June

I think these stocks stand out from the rest of the ASX 20 pack.

Read more »

A woman is very excited about something she's just seen on her computer, clenching her fists and smiling broadly.
Opinions

Potential buys: 2 compelling ASX shares I like

I think both of these investments are appealing.

Read more »